The JAK-STAT Signaling Pathway
Antihypertensive Drugs: Direct Renin Inhibitors
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Dipeptidyl Peptidase 4 Inhibitors
Inhibitors of Viral Protein Synthesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 24, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
1Division of Cellular Therapy and Division of Stem Cell Signaling, The Institute of Medical Science, The University of Tokyo, Japan.
Molecular-targeted therapies, including kinase inhibitors, show promise but lack specificity. STAT3 inhibitors are emerging as a promising alternative for cancer treatment due to STAT3
Area of Science: